Pathology Doctors in Delaware Medicare Details, Address, Contact
51 Pathology doctors found. Showing 41 - 51
 Dr. Jeffery L. Twiss, MD Pathology - Pediatric Pathology Medicare: Not Enrolled in Medicare Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 |
Frederick Tibuah, Pathology - Blood Banking & Transfusion Medicine Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 910-343-5300 |
Hang Zhou, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 701 N Clayton St, Msb, Suite 301, Wilmington, DE 19805 Phone: 302-575-8103 Fax: 302-575-8144 |
 Maria Brescia Queenan, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-4945 |
Dr. Valentina Markovsky, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 |
Mr. Kudakwashe R. Chikwava, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-298-7476 |
James Monihan, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 N Clayton St, Wilmington, DE 19805 Phone: 302-575-8090 |
Gary Samuel Rose, Pathology - Pediatric Pathology Medicare: Accepting Medicare Assignments Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-4945 |
Dr. Susan Margaret Donnelly, M.D. Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Limestone Rd Ste 103, Wilmington, DE 19808 Phone: 302-498-6304 Fax: 302-234-8682 |
Yongling Bian, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 N Clayton St, Wilmington, DE 19805 Phone: 302-575-8092 |
Dr. Bruce Zangwill, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 Fax: 302-633-5207 |
News Archive
EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer
EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.
Japanese researchers explain how inflammation causes gastric tumors
In 1982, researchers reported a link between chronic gastritis and stomach bacterium Helicobacter pylori, triggering a flurry of research into this newly-identified pathogen.
Alzheimer's prevention initiative: Shared risks and shared rewards
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
European Commission grants conditional marketing authorization for Pfizer's BOSULIF
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
› Verified 3 days ago